Market Growth, Innovation & Opportunities in 2026

South Africa’s respiratory medical devices market is expanding steadily as healthcare providers respond to rising rates of asthma, COPD, sleep apnea, tuberculosis-related lung damage, and post-viral respiratory complications. Demand is being driven by both hospital critical-care needs and a growing shift toward home-based respiratory therapy. From ventilators and oxygen concentrators to CPAP systems and nebulizers, respiratory technology is becoming a core part of the country’s healthcare future.

Why Demand Is Rising in South Africa

Several factors are accelerating the adoption of respiratory devices across the country:

Increasing chronic respiratory disease burden
Growth in private hospitals and specialized pulmonary clinics
Greater awareness of sleep disorders such as obstructive sleep apnea
Expansion of home healthcare services
Need for portable solutions during power interruptions and mobility challenges
Ongoing investments in ICU and emergency infrastructure

Key Respiratory Medical Devices in South Africa

1. Oxygen Concentrators

Oxygen concentrators remain one of the most essential respiratory devices in South Africa. They are used in hospitals, recovery centers, and home settings for patients requiring supplemental oxygen. The South African oxygen concentrator market generated approximately US$45.2 million in 2023 and is projected to reach US$54.2 million by 2030. Portable units are expected to grow fastest due to demand for mobility and convenience.

2. Ventilators

Ventilators are critical in ICUs, emergency rooms, and surgical settings. South Africa’s ventilator market was valued at US$31.3 million in 2023 and is forecast to reach US$46.3 million by 2030, showing strong growth in advanced critical-care capacity.

3. CPAP & PAP Devices

Continuous Positive Airway Pressure (CPAP), APAP, and BiPAP devices are increasingly used to manage sleep apnea and chronic breathing disorders. With more sleep labs and diagnostic services opening nationwide, PAP therapy is gaining traction in both public and private healthcare systems.

4. Nebulizers

Nebulizers remain widely used for asthma, bronchitis, and pediatric respiratory treatment. The local nebulizer segment is projected to grow from US$4.4 million in 2023 to US$6.3 million by 2030.

5. Oxygen Delivery Accessories

This includes masks, nasal cannulas, humidifiers, cylinders, and related consumables. It is one of the largest segments in the respiratory market, expected to grow from US$230.8 million in 2023 to US$351.5 million by 2030.

Hospital vs Homecare Opportunity

A major trend in South Africa is the movement from hospital-only care to home respiratory support. Patients increasingly prefer treatment at home when possible, especially for long-term oxygen therapy, sleep apnea, and chronic pulmonary disease management.

Hospital Demand Includes:

ICU ventilators
Emergency oxygen systems
High-flow therapy
Monitoring devices

Homecare Demand Includes:

Portable oxygen concentrators
CPAP machines
Nebulizers
Battery-backed devices
Remote monitoring solutions

This shift creates major opportunities for distributors, importers, and local service providers.

Leading Brands Active in the Market

Global respiratory device manufacturers with visibility in South Africa include:

ResMed
Philips Respironics
Fisher & Paykel Healthcare
Dräger
Medtronic
Hamilton Medical

Challenges in the South African Market

Despite strong potential, several barriers remain:

High import costs and currency volatility
Uneven access between urban and rural areas
Need for technician training and maintenance support
Budget pressure in public hospitals
Dependence on imported components and supply chains

Future Outlook

The respiratory medical devices sector in South Africa is expected to remain one of the most attractive segments in healthcare technology through 2030. Portable systems, connected devices, energy-efficient machines, and affordable homecare solutions are likely to lead the next phase of growth.

Companies that combine quality products with local service, training, and after-sales support will be best positioned to succeed.

Final Thoughts

South Africa’s respiratory care market is no longer limited to hospitals. It now spans homes, clinics, wellness centers, and digital care platforms. For manufacturers, distributors, healthcare investors, and entrepreneurs, the country presents a valuable opportunity in a fast-evolving medical technology space.